MedPath

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

Withdrawn
Conditions
Lung Cancer
Precancerous Condition
Malignant Mesothelioma
Metastatic Cancer
Nonmalignant Neoplasm
Registration Number
NCT00733252
Lead Sponsor
Case Comprehensive Cancer Center
Brief Summary

RATIONALE: Diagnostic procedures, such as optical coherence tomography, may help find and diagnose lung cancer or precancerous cells.

PURPOSE: This phase I trial is studying how well optical coherence tomography of the airway works in detecting abnormal cells in patients undergoing surgery for lung cancer or lung disease.

Detailed Description

OBJECTIVES:

* Correlate optical coherence tomography images of the airway with airway histology.

* Develop an imaging technique to detect premalignant airway epithelial changes (carcinoma in situ, dysplasia) to study the transformation process as well as intervene and prevent the development of lung cancer.

OUTLINE: Bronchoscopic imaging and optical coherence tomography are performed on lung tissue samples collected during surgery. All imaged areas are marked. The marked areas are then excised and fixed in formalin for histopathologic analysis.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation of optical coherence tomography images of the airway with airway histologyThis study will involve discarded tissue from 10 subjects with pathology specimens over one year.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath